|
As ordered reported by the House Committee on Veterans’ Affairs on July 12, 2018
As ordered reported by the House Committee on Veterans’ Affairs on July 12, 2018
As passed by the U.S. House of Representatives on July 10, 2018
As ordered reported by the House Committee on Natural Resources on July 11, 2018
As ordered reported by the House Committee on Natural Resources on July 11, 2018
In a letter to Congressman Mark Meadows, CBO explains its estimate for section 53116 of the Bipartisan Budget Act requiring brand-name prescription drug manufacturers to increase the discount offered to some Medicare Part D beneficiaries. 
CBO provides additional information to Congressman Mark Meadows about the budgetary treatment of the government’s payments to reimburse health care insurers for cost-sharing reductions they provide to eligible people. 
|
|
